Target intelligence / Profile preview

Alpha Kinase 1 T237M Mutant (ALPK1 T237M)

Target
ALPK1 T237M
Molecular classification
Enzyme, Protein Kinase, Serine/Threonine Kinase, Atypical Kinase, ALPK Kinase
01

Overview

The Alpha Kinase 1 T237M mutant (ALPK1 T237M) is a gain-of-function mutation of the ALPK1 protein, where threonine at position 237 is replaced by methionine. This mutation leads to constitutive activation of the NF-κB signaling pathway, even in the absence of the canonical bacterial ligand ADP-heptose. The mutant protein also exhibits altered ligand specificity responding abnormally to endogenous nucleotide sugars. This results in increased production of pro-inflammatory cytokines and is associated with ROSAH syndrome.

Other names
ALPK1 (T237M)ALPK1-T237MALPK1 with Threonine to Methionine substitution at position 237
02

Mechanism of action

Constitutive activation of NF-κB signaling pathway via TIFA-dependent activation in the absence of its canonical ligand. Aberrant recognition of endogenous nucleotide sugars.

03

Biological functions

Signal transductionInnate immune responseNF-κB pathway activationPhosphorylation
04

Disease associations

ROSAH syndromeInflammationGenetic Disease
05

Safety considerations

Uncontrolled inflammation due to constitutive NF-κB activationPotential for off-target effects due to altered ligand specificity
06

Biomarkers

Phosphorylation of IκBαPhosphorylation of IKKα/βPhosphorylation of MAP kinases p38 and JNKTNF-alpha levelsIL-6 levelsIL-8 levels

Beyond the preview

Go deeper on Alpha Kinase 1 T237M Mutant (ALPK1 T237M).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha Kinase 1 T237M Mutant (ALPK1 T237M).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call